Q3 2020 Holdings
Filed 2020-11-12 | 11 holdings | $32.3M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Crinetics Pharmaceuticals, Inc.(CRNX) | Common Stock | 22663K107 | $31.8M | 2,030,616 | 98.4% |
| Crispr Therapeutics AG(CRSP) | Common Stock | H17182108 | $303.8K | 3,631,656 | 0.9% |
| Adverum Biotechnologies, Inc.(ADVMCHF) | Common Stock | 00773U108 | $72.1K | 7,003,892 | 0.2% |
| Aprea Therapeutics, Inc. | Common Stock | 03836J102 | $44.6K | 1,854,229 | 0.1% |
| Flexion Therapeutics, Inc. | Common Stock | 33938J106 | $40.0K | 3,842,578 | 0.1% |
| Akero Therapeutics, Inc.(AKRO) | Common Stock | 00973Y108 | $23.9K | 777,727 | 0.1% |
| Ocular Therapeutix, Inc.(OCUL) | Common Stock | 67576A100 | $16.9K | 2,215,384 | 0.1% |
| Gritstone Oncology, Inc.(2JQ) | Common Stock | 39868T105 | $8.2K | 3,102,929 | 0.0% |
| CymaBay Therapeutics, Inc.(CBAYUSD) | Common Stock | 23257D103 | $3.9K | 543,753 | 0.0% |
| Clovis Oncology, Inc.(CLVSEUR) | Common Stock | 189464100 | $594 | 101,855 | 0.0% |
| Second Sight Medical Products, Inc. | Common Stock | 81362J100 | $484 | 561,612 | 0.0% |